Cell-therapy

Delve into the world of Cell-therapy in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on Cell-therapy to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Zymeworks Inks Global License and Collaboration Agreement with Roche for ZW209 – Up to USD 813 Million Deal for Novel DLL3‑Targeting Trispecific T Cell Engager
CompanyDeals

Zymeworks Inks Global License and Collaboration Agreement with Roche for ZW209 – Up to USD 813 Million Deal for Novel DLL3‑Targeting Trispecific T Cell Engager

Zymeworks Inc. (NASDAQ: ZYME) announced that it has entered into an exclusive global license and collaboration agreement with Roche for the research, development and commercialization of ZW209, a novel trispecific…

Bio‑Thera's BAT2306 Becomes World's First Secukinumab Biosimilar with NMPA Approval Across Psoriasis, Ankylosing Spondylitis and Psoriatic Arthritis

Bio‑Thera’s BAT2306 Becomes World’s First Secukinumab Biosimilar with NMPA Approval Across Psoriasis, Ankylosing Spondylitis and Psoriatic Arthritis

Eisai Issues First China Prescription for Leqembi (lecanemab) Subcutaneous Autoinjector at Ruijin Hainan Hospital – Home‑Friendly Dosing Marks New Era in Alzheimer's Treatment Access

Eisai Issues First China Prescription for Leqembi (lecanemab) Subcutaneous Autoinjector at Ruijin Hainan Hospital – Home‑Friendly Dosing Marks New Era in Alzheimer’s Treatment Access

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
DrugPolicy / Regulatory

CDE Releases Guidelines for Clinical Trials of Stem Cell Therapies and Derived Products

CompanyDeals

Shanghai Cell Therapy Group Partners with Nantong Federation for Comprehensive Health Services Platform

CompanyDrug

Cytocraft Biotech’s SDT-T002 Cell Therapy Approved for Advanced Liver Cancer by NMPA

CompanyDrug

Janssen Submits Additional Indication Application to FDA for Carvykti in Multiple Myeloma

CompanyDeals

Shanghai Fosun High Technology Partners with NICE for Joint Innovation Centers

CompanyDrug

Vcanbio Receives NMPA Approval for VUM02 Stem Cell Therapy in Liver Failure and ARDS

CompanyDeals

uBriGene Partners with Everlife Biomed to Advance iPSC Therapy Preparation

CompanyDrug

Gilead’s Kite Announces Breakthrough Phase III Results for Yescarta in r/r LBCL

Show More